Chowdhury BA - Search Results

1

The FDA and safe use of long-acting beta-agonists in the treatment of asthma.

Chowdhury BA, Dal Pan G. Chowdhury BA, et al. N Engl J Med. 2010 Apr 1;362(13):1169-71. doi: 10.1056/NEJMp1002074. Epub 2010 Feb 24. N Engl J Med. 2010. PMID: 20181964 Free article. No abstract available.

2

Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.

Chowdhury BA, Seymour SM, Levenson MS. Chowdhury BA, et al. N Engl J Med. 2011 Jun 30;364(26):2473-5. doi: 10.1056/NEJMp1104375. N Engl J Med. 2011. PMID: 21714647 No abstract available.

3

Inhaled Corticosteroids and LABAs - Removal of the FDA's Boxed Warning.

Seymour SM, Lim R, Xia C, Andraca-Carrera E, Chowdhury BA. Seymour SM, et al. Among authors: chowdhury ba. N Engl J Med. 2018 Jun 28;378(26):2461-2463. doi: 10.1056/NEJMp1716858. N Engl J Med. 2018. PMID: 29949485 Free article. No abstract available.

4

The risks and benefits of indacaterol--the FDA's review.

Chowdhury BA, Seymour SM, Michele TM, Durmowicz AG, Liu D, Rosebraugh CJ. Chowdhury BA, et al. N Engl J Med. 2011 Dec 15;365(24):2247-9. doi: 10.1056/NEJMp1109621. N Engl J Med. 2011. PMID: 22168640 Free article. No abstract available.

5

Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.

Karimi-Shah BA, Chowdhury BA. Karimi-Shah BA, et al. Among authors: chowdhury ba. N Engl J Med. 2015 Mar 26;372(13):1189-91. doi: 10.1056/NEJMp1500526. N Engl J Med. 2015. PMID: 25806913 No abstract available.

6

Treatment of mild asthma.

Chowdhury BA. Chowdhury BA. N Engl J Med. 2005 Jul 28;353(4):424-7; author reply 424-7. N Engl J Med. 2005. PMID: 16050059 No abstract available.

7

In vitro considerations to support bioequivalence of locally acting drugs in dry powder inhalers for lung diseases.

Lee SL, Adams WP, Li BV, Conner DP, Chowdhury BA, Yu LX. Lee SL, et al. Among authors: chowdhury ba. AAPS J. 2009 Sep;11(3):414-23. doi: 10.1208/s12248-009-9121-4. Epub 2009 Jun 3. AAPS J. 2009. PMID: 19495991 Free PMC article. Review.

8

Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.

Chin SJ, Durmowicz AG, Chowdhury BA. Chin SJ, et al. Among authors: chowdhury ba. Ann Am Thorac Soc. 2016 Feb;13(2):173-9. doi: 10.1513/AnnalsATS.201510-712PS. Ann Am Thorac Soc. 2016. PMID: 26650145

9

Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

Mann M, Chowdhury B, Sullivan E, Nicklas R, Anthracite R, Meyer RJ. Mann M, et al. Chest. 2003 Jul;124(1):70-4. doi: 10.1378/chest.124.1.70. Chest. 2003. PMID: 12853504 Clinical Trial.

10

Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.

Adams WP, Ahrens RC, Chen ML, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O'Connor D, Parikh N, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJ, Sharp SS, Suman JD, Weda M, Woodcock J, Yu L. Adams WP, et al. Among authors: chowdhury ba. J Aerosol Med Pulm Drug Deliv. 2010 Feb;23(1):1-29. doi: 10.1089/jamp.2009.0803. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20131983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page